Scientists say identification of two epigenetically different states in mouse model opens door to "entirely new world of ...

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

Learn how early developmental patterns can influence your lifetime cancer risk and the type of cancer that may develop.

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

“It is very rare for a compound to shrink tumors in mouse models of breast cancer, let alone completely eradicate those tumors with a single dose, so we are eager for ErSO-TFPy to advance for ...

Now, researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic ...

Glycolysis is an important sugar degradation pathway that cancer cells in particular depend on. Scientists at the German Cancer Research Center (DKFZ) have now shown that liver cancer cells in mice ...